Evidence map›Paper›PMID 29423084›Full record

ArticleOncotarget2018

Similarity and difference in tumor-infiltrating lymphocytes in original tumor tissues and those of

Lili Ren, Tatsuo Matsuda, Boya Deng, Kazuma Kiyotani, Taigo Kato, Jae-Hyun Park, Tanguy Y Seiwert, Everett E Vokes, Nishant Agrawal, Yusuke Nakamura

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Lili RenDepartment of Medicine, The University of Chicago, Chicago, IL, USA.
Tatsuo MatsudaDepartment of Medicine, The University of Chicago, Chicago, IL, USA.
Boya DengDepartment of Medicine, The University of Chicago, Chicago, IL, USA.
Kazuma KiyotaniCancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan.
Taigo KatoDepartment of Medicine, The University of Chicago, Chicago, IL, USA.
Jae-Hyun ParkDepartment of Medicine, The University of Chicago, Chicago, IL, USA.
Tanguy Y SeiwertDepartment of Medicine, The University of Chicago, Chicago, IL, USA.
Everett E VokesDepartment of Medicine, The University of Chicago, Chicago, IL, USA.
Nishant AgrawalDepartment of Surgery, The University of Chicago, Chicago, IL, USA.
Yusuke NakamuraDepartment of Medicine, The University of Chicago, Chicago, IL, USA.
University of Chicago · USJapanese Foundation For Cancer Research · JPShenzhen Second People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Though adoptive tumor-infiltrating lymphocyte (TIL) therapy has been explored in clinical trials for many years, there is little information for the clonotype composition between TILs in original tumor tissues and TILs that were

Indexed as

mismatch repairnon-synonymous mutationsquamous cell carcinoma of head and neck cancerT cell receptortumor-infiltrating lymphocytes

Identifiers

PMID29423084
PMCPMC5790501
OpenAlexW2776758774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.